These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3510284)

  • 1. Prognostic factors and staging in multiple myeloma: a reappraisal.
    Bataille R; Durie BG; Grenier J; Sany J
    J Clin Oncol; 1986 Jan; 4(1):80-7. PubMed ID: 3510284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Merlini, Waldenström, Jayakar staging system revisited.
    Merlini G; Gobbi PG; Ascari E
    Eur J Haematol Suppl; 1989; 51():105-10. PubMed ID: 2697581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plea to overcome the concept of "staging" and related inadequacy in multiple myeloma.
    Gobbi PG; Bertoloni D; Grignani G; Pieresca C; Rossi A; Rutigliano L; Merlini G; Riccardi A; Ascari E
    Eur J Haematol; 1991 Mar; 46(3):177-81. PubMed ID: 2009950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two staging systems for myeloma.
    Vercelli D; Cozzolino F; Di Guglielmo R
    Nouv Rev Fr Hematol (1978); 1981; 23(2):107-10. PubMed ID: 7290984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International staging system for multiple myeloma.
    Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
    J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF; Fu WJ; Chen YB; Yuan ZG; Wang DX; Hou J
    Ai Zheng; 2006 Apr; 25(4):461-4. PubMed ID: 16613681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.
    Bataille R; Boccadoro M; Klein B; Durie B; Pileri A
    Blood; 1992 Aug; 80(3):733-7. PubMed ID: 1638024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients.
    Bataille R; Grenier J; Sany J
    Blood; 1984 Feb; 63(2):468-76. PubMed ID: 6362753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
    Scudla V; Budíková M; Fischerová E; Zadrazil J; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():201-12. PubMed ID: 1838869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis].
    Scudla V; Budíková M; Fischerová E; Raska I; Vavrdová V
    Vnitr Lek; 1991 Apr; 37(4):342-51. PubMed ID: 2053304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T
    Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience.
    Jacobson JL; Hussein MA; Barlogie B; Durie BG; Crowley JJ;
    Br J Haematol; 2003 Aug; 122(3):441-50. PubMed ID: 12877671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic implications of myeloma staging.
    Durie BG; Bataille R
    Eur J Haematol Suppl; 1989; 51():111-6. PubMed ID: 2697583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group.
    Pelliniemi TT; Irjala K; Mattila K; Pulkki K; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
    Blood; 1995 Feb; 85(3):765-71. PubMed ID: 7530507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical considerations on a comparative study of two staging systems for multiple myeloma.
    Merlini G; Jayakar D
    Nouv Rev Fr Hematol (1978); 1984; 26(6):397-400. PubMed ID: 6527945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.
    Bataille R; Durie BG; Grenier J
    Br J Haematol; 1983 Nov; 55(3):439-47. PubMed ID: 6357266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.